EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Five-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Women: A Systematic Review and Meta-Analysis

Seth E M Wolf iD, John A Kucera, Alexander C Gregg iD, Antonino Di Franco iD, Mohamed Rahouma, Bjorn Redfors, Michael Reardon, Andres M Pineda, Jeffrey G Gaca, Brittany A Zwischenberger iD

European Journal of Cardio-Thoracic Surgery · 01.12.2025 · 67 (12)

DOI: 10.1093/ejcts/ezaf400 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 13.11.2025. Verfasst von Seth E M Wolf und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710-1000, United States. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation, Aortic Valve. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: NHLBI NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Women patients with aortic stenosis (AS) exhibit distinct anatomic and physiologic features that may influence outcomes after valve replacement. While transcatheter aortic valve replacement (TAVR) has shown early advantages over surgical aortic valve replacement (SAVR) in women, long-term sex-specific outcomes remain unclear. To evaluate outcomes at 5 years comparing TAVR versus SAVR a systematic review and meta-analysis was performed.

Methods

A systematic literature review was conducted, identifying all randomized controlled trials (RCTs) comparing TAVR with SAVR which included women with completed 5-year follow-up. The primary outcome was the composite of all-cause mortality or disabling stroke. Meta-analysis was performed using both random-effects and fixed-effect models. The study protocol was registered in PROSPERO (CRD420251004394).

Results

Six RCTs were included with a total of 3094 women (1587 TAVR and 1507 SAVR). Overall, no significant difference was observed in the primary outcome between TAVR and SAVR (incidence rate ratios [IRRs] 1.00, 95% confidence interval [CI]: 0.88-1.13, P = .98). Meta-regression did not find any association between key clinical covariates and the primary outcome. Trial sequential analysis demonstrated that the extracted sample size met the required information size, but a definitive treatment effect was not confirmed.

Conclusions

While TAVR shows an advantage over SAVR at 1-year follow-up in women, all-cause mortality or disabling stroke is similar in TAVR and SAVR at 5 years. Future studies must include sex-disaggregated reporting of both primary and secondary outcomes in order to comprehensively weigh risks and benefits of each intervention and inform personalized treatment strategies. Clinical registration number The study protocol was registered in PROSPERO (CRD420251004394).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisHeart Valve Prosthesis ImplantationAortic ValveHumansFemaleTreatment OutcomeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

aortic stenosisaortic valve replacementsex-specific outcomes

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710-1000, United States.
  • Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, 10021, United States.
  • Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, 10021, United States.
  • Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, 41345, Sweden.
  • Department of Molecular and Clinical Medicine, Gothenburg University, Gothenburg, 41124, Sweden.
  • Department of Cardiovascular Surgery, Houston Methodist Hospital, Houston, TX, 77030, United States.

ORCID-Profile: Seth E M Wolf, Alexander C Gregg, Antonino Di Franco, Brittany A Zwischenberger

Förderung

  • NHLBI NIH HHS
  • National Institute of Health

Zitieren

APA

Wolf, S. E. M., Kucera, J. A., Gregg, A. C., Di Franco, A., Rahouma, M., Redfors, B., Reardon, M., Pineda, A. M., Gaca, J. G., & Zwischenberger, B. A. (2025). Five-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Women: A Systematic Review and Meta-Analysis. European Journal of Cardio-Thoracic Surgery, 67(12). https://doi.org/10.1093/ejcts/ezaf400

Vancouver

Wolf SEM, Kucera JA, Gregg AC, Di Franco A, Rahouma M, Redfors B, et al. Five-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Women: A Systematic Review and Meta-Analysis. European Journal of Cardio-Thoracic Surgery. 2025;67(12). doi:10.1093/ejcts/ezaf400

BibTeX
@article{Wolf2025,
  author = {Wolf, Seth E M and Kucera, John A and Gregg, Alexander C and Di Franco, Antonino and Rahouma, Mohamed and Redfors, Bjorn and Reardon, Michael and Pineda, Andres M and Gaca, Jeffrey G and Zwischenberger, Brittany A},
  title = {Five-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Women: A Systematic Review and Meta-Analysis},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  volume = {67},
  number = {12},
  doi = {10.1093/ejcts/ezaf400}
}
Kostenlos starten →